Denali Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AMPH
Denali Advisors's AMPH Position: Q2 2026 in Review
Denali Advisors increased its Amphastar Pharmaceuticals (AMPH) stake by 41% in Q2 2026, buying an estimated $2.21M and bringing the position to 375,965 shares worth $7.59M. The position accounts for 0.76% of the portfolio, ranked #37.
Denali Advisors first reported a position in AMPH in Q4 2021 and has held it in 5 quarters since. 212 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.
- Denali Advisors held 375,965 shares of Amphastar Pharmaceuticals worth $7.59M as of Q2 2026.
- Denali Advisors bought 109,500 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $2.21M.
- Amphastar Pharmaceuticals made up 0.76% of Denali Advisors's portfolio in Q2 2026, its #37 holding.
- Denali Advisors first reported a position in Amphastar Pharmaceuticals in Q4 2021 and has held it in 5 quarters since.
- 212 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.
Based on Denali Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.